基于病毒载体的治疗性HPV疫苗
Teng Ji1,2, Yuchuan Liu3, Yutong Li3
1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Clinical and experimental medicine
|August 28, 2024
概括
复制缺陷的病毒载体疫苗为人类乳头瘤病毒 (HPV) 感染提供了强大的免疫反应. 本综述详细介绍了治疗性HPV病毒载体疫苗,包括疗效和临床试验进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 人类乳头瘤病毒 (HPV) 与许多癌症有关,特别是与HPV16相关的恶性瘤.
- 使用病毒载体的治疗性HPV疫苗正在出现,用于治疗HPV诱导的瘤和前恶性病变.
- 与病毒载体方法相比,传统的子单位疫苗有局限性.
研究的目的:
- 审查目前治疗性HPV病毒载体疫苗的现状.
- 要总结HPV感染,抗原选择和载体技术.
- 讨论临床前模型,临床试验进展和HPV疫苗的疗效.
主要方法:
- 对评估疫苗疗效的临床前模型的审查.
- 对治疗性HPV病毒载体疫苗的当前研究进行分析.
- 临床试验数据摘要,包括指示和组合疗法.
主要成果:
- 病毒载体疫苗诱导强大的抗体和细胞免疫反应,没有辅助剂.
- 许多治疗性HPV疫苗候选人正在开发中.
- 临床前模型提供了关于疫苗疗效的见解,目前正在进行的临床试验显示出有希望.
结论:
- 治疗性HPV病毒载体疫苗代表了对抗HPV相关癌症的有希望的战略.
- 为了最佳的抗原选择和方法优化,需要进一步的研究.
- 本综述提供了该领域的全面概述,突出了进展和未来的方向.
相关概念视频
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


